GATTAZZO, CRISTINA
 Distribuzione geografica
Continente #
NA - Nord America 2.125
EU - Europa 342
AS - Asia 311
OC - Oceania 3
AF - Africa 1
SA - Sud America 1
Totale 2.783
Nazione #
US - Stati Uniti d'America 2.125
CN - Cina 201
IT - Italia 115
SG - Singapore 73
DE - Germania 61
FI - Finlandia 58
GB - Regno Unito 39
SE - Svezia 37
VN - Vietnam 19
FR - Francia 14
IN - India 11
IE - Irlanda 4
UA - Ucraina 4
AU - Australia 3
NL - Olanda 3
RU - Federazione Russa 2
TR - Turchia 2
BG - Bulgaria 1
CH - Svizzera 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
HU - Ungheria 1
JO - Giordania 1
JP - Giappone 1
KR - Corea 1
KW - Kuwait 1
LK - Sri Lanka 1
NG - Nigeria 1
Totale 2.783
Città #
Fairfield 295
Woodbridge 259
Chandler 246
Houston 197
Ashburn 161
Ann Arbor 148
Cambridge 123
Seattle 108
Wilmington 104
Singapore 49
Beijing 43
Padova 41
Des Moines 37
Helsinki 33
Princeton 32
Nanjing 30
Boardman 27
Jacksonville 26
San Diego 25
Medford 22
Dong Ket 19
New York 15
Guangzhou 14
Falls Church 11
Santa Clara 11
Jinan 9
Redwood City 9
Shenyang 9
Changsha 8
Milan 8
Cagliari 6
Dallas 6
Hebei 5
Nanchang 5
Roxbury 5
Shanghai 5
Chicago 4
Dublin 4
Hangzhou 4
Los Angeles 4
Pune 4
Amsterdam 3
Formia 3
Haikou 3
Indiana 3
Jiaxing 3
Melbourne 3
Norwalk 3
Phoenix 3
Auburn Hills 2
Baotou 2
Bologna 2
Borås 2
Castelfranco di Sotto 2
Fuzhou 2
Hefei 2
Hounslow 2
Kunming 2
London 2
Luzzara 2
Marcon 2
Ningbo 2
Nürnberg 2
Paris 2
Parma 2
Piazzola Sul Brenta 2
Rosà 2
Taiyuan 2
Taizhou 2
Tianjin 2
Valsamoggia 2
Washington 2
Wuhan 2
Zhengzhou 2
Acton 1
Ahmedabad 1
Alghero 1
Amman 1
Ankara 1
Avenel 1
Bari 1
Bolzano 1
Budapest 1
Buffalo Junction 1
Copenhagen 1
Cormeilles-en-Parisis 1
Council Bluffs 1
Dambulla 1
Edinburgh 1
Falkenstein 1
Frankfurt am Main 1
Fulham 1
Hanover 1
Islington 1
Kuwait City 1
Lafayette 1
Lagos 1
Lanzhou 1
Mapo-gu 1
Martellago 1
Totale 2.271
Nome #
3-(2,4-Dichlorophenyl)-4-(1-methyl-1H-indol-3-yl)-1H-pyrrole-2,5-dione (SB216763), a Glycogen Synthase Kinase-3 Inhibitor, Displays Therapeutic Properties in a Mouse Model of Pulmonary Inflammation and Fibrosis 158
Activating KIRs in Chronic Lymphoproliferative Disorder of NK Cells: Protection from Viruses and Disease Induction? 154
Cortactin, another player in the Lyn signaling pathway, is overexpressed and alternatively spliced in leukemic cells from patients with B-cell Chronic Lymphocytic Leukemia. 150
STAT3 mutation impacts biological and clinical features of T-LGL leukemia 149
Profiling B cell chronic lymphocytic leukemia by reverse phase protein array: Focus on apoptotic proteins 141
Cortactin, a Lyn substrate, is a checkpoint molecule at the intersection of BCR and CXCR4 signalling pathway in chronic lymphocytic leukaemia cells. 133
Sarcoidosis is a Th1/Th17 multisystem disorder 131
Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia 131
Integrated CLL Scoring System, a New and Simple Index to Predict Time to Treatment and Overall Survival in Patients With Chronic Lymphocytic Leukemia 126
Cross-talk between chronic lymphocytic leukemia (CLL) tumor B cells and mesenchymal stromal cells (MSCs): implications for neoplastic cell survival 124
Leukaemic cells from chronic lymphocytic leukaemia patients undergo apoptosis following microtubule depolymerization and Lyn inhibition by nocodazole. 119
Lack of expression of inhibitory KIR3DL1 receptor in patients with natural killer cell-type lymphoproliferative disease of granular lymphocytes 113
Geldanamycin-induced Lyn dissociation from aberrant Hsp90-stabilized cytosolic complex is an early event in apoptotic mechanisms in B-chronic lymphocytic leukemia. 107
Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells. 105
Lyn-mediated SHP-1 recruitment to CD5 contributes to resistance to apoptosis of B-cell chronic lymphocytic leukemia cells. 100
Lyn-mediated procaspase 8 dimerization blocks apoptotic signaling in B-cell chronic lymphocytic leukemia. 97
HS1, a Lyn Kinase Substrate, Is Abnormally Expressed in B-Chronic Lymphocytic Leukemia and Correlates with Response to Fludarabine-Based Regimen. 95
Intrinsic and Estrinsic Mechanism Contributes to Maintain the JAK/STAT Pathway Aberrantly Activated in T-Type Large Granular Lymphocyte Leukemia 93
CLL patients carrying 13q deletion show clinical heterogenity according to IGVH mutational status and CD38 expression 88
Increased Survival and Migration of CLL B-Cells in the Presence of Marrow Mesenchymal Stromal Cells: Novel Findings for Microenvironment-Targeted Therapies 81
S1P1 expression is controlled by the pro-oxidant activity of p66Shc and is impaired in B-CLL patients with unfavorable prognosis. 76
Role of inflammation in the development of lung fibrosis and in the pathogenesis of pulmunary hypertension 66
Phosphorylation of PP2A by Lyn is a key phenomenon in the cancer phenotype of B-CLL 64
B cells from Chronic Lymphocytic Leukemia undergo apoptosis following microtubule depolymerization by nocodazole 62
Are T-LGL Leukemia and NK-Chronic Lymphoproliferative Disorder really two distinct diseases? 55
CLL patients with low-risk cytogenetic abnormalities show clinical heterogeneity according to IGVH mutational status and CD38 expression 51
Leukemic cell from B-CLL patients display heterogeneous response to the anti-apoptotic effect of mesenchymal stromal cells 49
Totale 2.818
Categoria #
all - tutte 9.924
article - articoli 9.616
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.540


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020457 0 0 0 28 54 37 64 65 62 81 39 27
2020/2021359 32 27 13 23 18 21 12 40 46 50 46 31
2021/2022407 12 36 41 61 15 24 17 50 15 3 34 99
2022/2023464 77 56 14 79 55 58 5 28 59 5 25 3
2023/2024232 8 31 23 17 25 47 8 18 2 22 14 17
2024/2025139 0 51 47 41 0 0 0 0 0 0 0 0
Totale 2.818